- Top investment opportunities
- Startup of the Week: SynergyMed, transforming surgery with 3D printing and visualization
- Women tech leaders in the spotlight at OurCrowd Summit
- OurCrowd in UAE: Why AI? Why Abu Dhabi?
- Bionaut Labs raises $43.2M Series B
- UBS joins Shield investors in $20M Series B
- C2A Security brings full lifecycle EV protection to Asian market
- OurCrowd hosts German business executives
- Teampay raises $47M, expands partnership with MasterCard
- UK's Poolbeg Pharma uses CytoReason's AI-model to identify new flu drugs
- UK's ClearBank adopts ThetaRay's anti-money laundering platform
- Top wineries use Trellis' AI to boost efficiency, sustainability
- More than 4,200 high-tech jobs
Startup of the Week:
SynergyMed: Transforming surgery with 3D printing and visualization
3D printing is revolutionizing industries from automotive to robotics. SynergyMed, a California-based startup, plans to bring its unique 3D technology SaaS platform into healthcare with proprietary visualization and printing capabilities that significantly improve patient results while cutting providers' costs. Among its many capabilities, the hardware-agnostic system allows medical professionals to design and 3D print patient-specific surgical tools and implants. SynergyMed's platform is ISO-certified for use in Europe, and has assisted over 1,200 surgical procedures to date across 16 surgical disciplines in 25 hospitals in Israel, Spain and the UK. As the company looks to expand into the US and seek FDA clearance, it has signed an agreement with Israel's largest HMO, which will use its technology in hundreds of procedures at top hospitals. OurCrowd is leading SynergyMed's current funding round.
Women tech leaders in the spotlight at OurCrowd Summit
Some of the tech world's most inspiring women leaders will take center stage at the OurCrowd Global Investor Summit on Feb. 15th, 2023. Melissa Drew, Digital Transformation Executive Advisor at IBM, is a world expert on procurement and supply chain issues. She is also a founding member of Women Leaders in Data. Dr. Gilly Regev is the CEO and Co-founder of SaNOtize, creators of the anti-viral nasal spray proven effective against Covid. Lara Ramdin, Chief Innovation Officer at Dole Foods, will talk about new directions in alternative proteins. Also addressing the future of FoodTech are Noga Sela Shalev, CEO of the FreshStart Food Incubator, Maya Ashkenazi Otmazgin, CEO and Co-founder of Maolac, and Efrat Boker Ferri, CEO of Sufresca. Tickets for the Summit in Jerusalem are limited. To reserve your place, register now.
OurCrowd in UAE: Why AI? Why Abu Dhabi?
In November, we announced the establishment of Integrated Data Intelligence Ltd., OurCrowd's first R&D center outside Israel. This new company, based in Abu Dhabi, will develop artificial intelligence for business. It is the result of a $60M joint commitment by OurCrowd and the Innovation Programme of the Abu Dhabi Investment Office (ADIO). Why artificial intelligence, and why Abu Dhabi? I explain the thinking behind this new initiative in my new 'Investors on the Frontlines' column.
Bionaut Labs raises $43.2M Series B
MedTech pioneer Bionaut Labs raised $43.2M in Series B funding, TechCrunch reports. The company's magnetically driven micro robots deliver therapeutics directly to the midbrain, unlike standard drugs that are delivered mostly intravenously or orally. Bionaut targets several debilitating conditions, including Parkinson's disease, Dandy-Walker Syndrome, Huntington's disease and certain types of malignant brain tumors. OurCrowd participated alongside lead investor Khosla Ventures. "We are extremely excited about the transformative potential Bionaut presents in treating debilitating neurological disorders," says Vinod Khosla, Founder of Khosla Ventures. "Anatomically precise treatment will make traditionally used methods seem archaic, and Bionaut is at the forefront of this movement."
UBS joins Shield investors in $20M Series B
Our portfolio company Shield raised $20M for its AI-powered workplace intelligence platform, VentureBeat reports. Shield enables financial institutions to detect market abuse and automate surveillance over all employee communication channels, saving operational and compliance costs. Through its venture and innovation unit UBS Next, UBS joined OurCrowd, Mindset Ventures and lead investor Macquarie Capital in the Series B round. "We strongly believe in the value Shield can bring to financial organizations, and Macquarie is pleased to continue supporting Shield as it delivers real benefit to an increasing range of customers," says David Standen, Global Co-head of Macquarie Capital.
C2A Security brings full lifecycle EV protection to Asian market
As more countries look to adopt more electric vehicles (EVs), the danger of cyberattacks grows, with the entire infrastructure susceptible to hackers. Our portfolio company C2A Security created EVSec, a comprehensive cybersecurity management system that protects the vehicle, charging station, grid and the communication protocols among them, DigiTimes Asia reports. Israel-based C2A is focusing on the Asian market, partnering with Chinese OS giant ThunderSoft. The companies will offer tools for OEMs and suppliers in China to identify and respond to cyberattacks. "I think the key to successful penetration into Asia is having a more significant local presence and making sure that the solution is customized for the Asian market," says Roy Fridman, CEO of C2A. The number of EV charging stations in China is growing steadily as the country expands adoption of electric and connected vehicles. C2A Security is currently funding on the OurCrowd platform.
OurCrowd hosts German business executives
OurCrowd hosted a delegation from German Trade and Invest, a government-sponsored initiative, and Berlin Partner, which promotes international technology collaboration. The German business leaders and academics learned about the latest advances in additive and smart manufacturing and 3D printing from our portfolio companies Largix and MultiVu.
0 Comments